Literature DB >> 28284351

Is MuSK myasthenia gravis linked to IgG4-related disease?

Pooja Raibagkar1, Judith A Ferry2, John H Stone3.   

Abstract

Immunoglobulin (Ig) G4-related disease (IgG4-RD) is an immune-mediated inflammatory condition that affects a wide variety of sites, including the nervous system, where it can involve the meninges or the pituitary gland, and cause perineural mass lesions. A large subset of acetylcholine receptor antibody (Ab)-negative myasthenia gravis (MG) patients has muscle-specific tyrosine kinase (MuSK) Abs, generally of the IgG4 subclass. There has not been any association found between IgG4-RD and MuSK MG yet. We report the first case of MuSK MG associated with lymphadenopathy with histopathology consistent with IgG4-RD. A 54-year-old woman with MuSK MG developed eight compression fractures related to steroid therapy. Eighteen months after initial presentation she was found to have retroperitoneal lymphadenopathy with biopsy findings consistent with IgG4-RD. She was started on rituximab with clinical improvement and ability to taper immunomodulatory agents for the first time. Our case raises number of questions regarding a potential link between MuSK MG and IgG4-RD which may shed further light on the pathophysiology and management of these diseases.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28284351     DOI: 10.1016/j.jneuroim.2017.02.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

1.  High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria.

Authors:  Raffi Topakian; Fritz Zimprich; Stephan Iglseder; Norbert Embacher; Michael Guger; Karl Stieglbauer; Dieter Langenscheidt; Jakob Rath; Stefan Quasthoff; Philipp Simschitz; Julia Wanschitz; David Windisch; Petra Müller; Dierk Oel; Günther Schustereder; Stefan Einsiedler; Christian Eggers; Wolfgang Löscher
Journal:  J Neurol       Date:  2019-01-16       Impact factor: 4.849

Review 2.  A New Classification System for IgG4 Autoantibodies.

Authors:  Inga Koneczny
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

3.  Anti-Neuronal IgG4 Autoimmune Diseases and IgG4-Related Diseases May Not Be Part of the Same Spectrum: A Comparative Study.

Authors:  Verena Endmayr; Cansu Tunc; Lara Ergin; Anna De Rosa; Rosa Weng; Lukas Wagner; Thin-Yau Yu; Andreas Fichtenbaum; Thomas Perkmann; Helmuth Haslacher; Nicolas Kozakowski; Carmen Schwaiger; Gerda Ricken; Simon Hametner; Sigrid Klotz; Lívia Almeida Dutra; Christian Lechner; Désirée de Simoni; Kai-Nicolas Poppert; Georg Johannes Müller; Susanne Pirker; Walter Pirker; Aleksandra Angelovski; Matus Valach; Michelangelo Maestri; Melania Guida; Roberta Ricciardi; Florian Frommlet; Daniela Sieghart; Miklos Pinter; Karl Kircher; Gottfried Artacker; Romana Höftberger; Inga Koneczny
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

4.  Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients.

Authors:  Umberto Basile; Mariapaola Marino; Cecilia Napodano; Krizia Pocino; Paolo Emilio Alboini; Francesca Gulli; Amelia Evoli; Carlo Provenzano; Emanuela Bartoccioni
Journal:  J Immunol Res       Date:  2018-03-25       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.